Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway

• Main Authors: Han X (Author), Yang Y (Author), Zhang M (Author), Li L (Author), Xue Y (Author), Jia Q (Author), Wang X (Author), Guan S (Author)
• Format: Book
• Published: Dove Medical Press, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Xue Han,1,* Yakun Yang,1,* Muqing Zhang,2,3 Li Li,4 Yucong Xue,2 Qingzhong Jia,4 Xiangting Wang,2,5 Shengjiang Guan3,6 1School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China; 2College of Integrative Medicine, Hebei University of Chine...